NASDAQ: TCRT
Alaunos Therapeutics Inc Stock Ownership - Who owns Alaunos Therapeutics?

Insider buying vs selling

Have Alaunos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert W. PostmaDirector2025-04-1320,804$2.92
$60.75kBuy
Jaime VieserDirector2024-12-312,182$2.01
$4.39kSell
Jaime VieserDirector2024-12-31818$2.00
$1.64kSell

1 of 1

TCRT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCRT insiders and whales buy or sell their stock.

TCRT Shareholders

What type of owners hold Alaunos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk690.46%11,056,069$27.09MInsider
Robert W. Postma269.76%4,319,588$10.58MInsider
Essex Woodlands Health Ventures Fund VI L P148.11%2,371,642$5.81MInsider
Laurence James Neil Cooper112.37%1,799,280$4.41MInsider
Jaime Vieser85.46%1,368,359$3.35MInsider
Paloma International L P75.84%1,214,456$2.98MInsider
Lindsay A. Md Rosenwald75.84%1,214,455$2.98MInsider
Kevin S. Boyle Sr.49.85%798,236$1.96MInsider
Jonathan 1. Lewis46.50%744,595$1.82MInsider
James Anthony Cannon24.86%398,050$975.22kInsider

1 of 3

TCRT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCRT0.25%99.75%Net BuyingNet Buying
SXTP4.75%95.25%Net Buying
MBIO86.72%13.28%Net SellingNet Selling
CDT12.56%87.44%Net SellingNet Buying
TOVX1.24%8.98%

Alaunos Therapeutics Stock Ownership FAQ

Who owns Alaunos Therapeutics?

Alaunos Therapeutics (NASDAQ: TCRT) is owned by 4.50% institutional shareholders, 1,813.93% Alaunos Therapeutics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Alaunos Therapeutics shareholder, owning 11.06M shares representing 690.46% of the company. Randal J. Kirk's Alaunos Therapeutics shares are currently valued at $26.31M.

If you're new to stock investing, here's how to buy Alaunos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.